Association between the soluble epoxide hydrolase gene and preeclampsia

Association between the soluble epoxide hydrolase gene and preeclampsia

Objective: In this study the association between K55R polymorphism, methylation level of the EPHX2 promoter region, and PE was investigated in 520 individuals including 260 PE patients and 260 healthy pregnant women. Methods: K55R polymorphism and methylation level of the EPHX2 promoter were determi...

Full description

Bibliographic Details
Main Authors:	Ismail Sari, Hatice Pinarbasi, Ergun Pinarbasi, Caglar Yildiz
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2017-10-01
Series:	Hypertension in Pregnancy
Subjects:	soluble epoxide hydrolase genetic polymorphism epoxyeicosatrienoic acid methylation
Online Access:	http://dx.doi.org/10.1080/10641955.2017.1388390

Similar Items

Association of the sEH gene promoter polymorphisms and haplotypes with preeclampsia
by: Sarı İsmail, et al.
Published: (2020-01-01)

Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson’s Disease: A New Therapeutic Strategy
by: Mercè Pallàs, et al.
Published: (2020-05-01)

Ureas derived from camphor and fenchone reveal enantiomeric preference of human soluble epoxide hydrolase
by: Vladimir Burmistrov, et al.
Published: (2022-01-01)

Inhibition of Soluble Epoxide Hydrolase Does Not Promote or Aggravate Pulmonary Hypertension in Rats
by: Matthieu Leuillier, et al.
Published: (2023-02-01)

Regulation of soluble epoxide hydrolase in renal-associated diseases: insights from potential mechanisms to clinical researches
by: Peng Gao, et al.
Published: (2024-02-01)

Soluble epoxide hydrolase gene deletion improves blood flow and reduces infarct size after cerebral ischemia in reproductively senescent female mice
by: Kristen L Zuloaga, et al.
Published: (2015-01-01)

The involvement of soluble epoxide hydrolase in the development of cardiovascular diseases through epoxyeicosatrienoic acids
by: Shan Jiang, et al.
Published: (2024-04-01)

Redox Regulation of Soluble Epoxide Hydrolase—Implications for Cardiovascular Health and Disease
by: Rebecca Charles, et al.
Published: (2022-06-01)

The impact of the soluble epoxide hydrolase cascade on periodontal tissues
by: Henrique Ballassini Abdalla, et al.
Published: (2023-02-01)

Role of soluble epoxide hydrolase in pain and depression comorbidity
by: Yuchen Bu, et al.
Published: (2024-04-01)

Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer’s disease
by: Hsueh-Te Lee, et al.
Published: (2019-12-01)

Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease
by: Věra Čertíková Chábová, et al.
Published: (2018-03-01)

Evaluation of the Therapeutic Potential of Sulfonyl Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors
by: Biswajit Kundu, et al.
Published: (2024-06-01)

Sexually Dimorphic Regulation of EET Synthesis and Metabolism: Roles of Estrogen
by: An Huang, et al.
Published: (2018-10-01)

Soluble Epoxide Hydrolase Inhibitor: A Novel Potential Therapeutic or Prophylactic Drug for Psychiatric Disorders
by: Qian Ren, et al.
Published: (2019-04-01)

Inside epoxyeicosatrienoic acids and cardiovascular disease
by: Stefania eTacconelli, et al.
Published: (2014-11-01)

Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients
by: Thomas Duflot, et al.
Published: (2019-03-01)

ZDHXB-101 (3′,5-Diallyl-2, 4′-dihydroxy-[1,1′-biphen-yl]-3,5′-dicarbaldehyde) protects against airway remodeling and hyperresponsiveness via inhibiting both the activation of the mitogen-activated protein kinase and the signal transducer and activator of transcription-3 signaling pathways
by: Jun-xia Jiang, et al.
Published: (2020-01-01)

Structure-guided discovery of potent and oral soluble epoxide hydrolase inhibitors for the treatment of neuropathic pain
by: Fangyu Du, et al.
Published: (2022-03-01)

Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis
by: Cindy B. McReynolds, et al.
Published: (2019-05-01)

2-(Piperidin-4-yl)acetamides as Potent Inhibitors of Soluble Epoxide Hydrolase with Anti-Inflammatory Activity
by: Juan Martín-López, et al.
Published: (2021-12-01)

Screening and Identification of Novel Soluble Epoxide Hydrolase Inhibitors from Corn Gluten Peptides
by: Jiamin Dang, et al.
Published: (2022-11-01)

Inhibitory Activity of Quaternary Isoquinoline Alkaloids on Soluble Epoxide Hydrolase
by: Jang Hoon Kim, et al.
Published: (2022-09-01)

Screening, Identification and Mechanism of Action of Cod-Derived Soluble Epoxide Hydrolase Inhibitory Peptides Based on Pharmacophore Model
by: LIU Pan, TU Maolin, LIU Hanxiong, CHENG Shuzhen, XU Xianbing, DU Ming
Published: (2023-03-01)

Soluble epoxide hydrolase inhibition alleviates chemotherapy induced neuropathic pain
by: Ashley A. Takeshita, et al.
Published: (2023-01-01)

Early Renal Vasodilator and Hypotensive Action of Epoxyeicosatrienoic Acid Analog (EET-A) and 20-HETE Receptor Blocker (AAA) in Spontaneously Hypertensive Rats
by: Agnieszka Walkowska, et al.
Published: (2021-01-01)

Soluble Epoxide Hydrolase and Brain Cholesterol Metabolism
by: Michelle Flores Domingues, et al.
Published: (2020-01-01)

Structure-function relationship between soluble epoxide hydrolases structure and their tunnel network
by: Karolina Mitusińska, et al.
Published: (2022-01-01)

Soluble Epoxide Hydrolase Inhibitory Activity of Selaginellin Derivatives from Selaginella tamariscina
by: Jang Hoon Kim, et al.
Published: (2015-12-01)

Inhibition of soluble epoxide hydrolase reverses bone loss in periodontitis by upregulating EMCN and inhibiting osteoclasts
by: Juanjuan Li, et al.
Published: (2024-11-01)

Deficiency of Soluble Epoxide Hydrolase Protects Cardiac Function Impaired by LPS-Induced Acute Inflammation
by: Victor Samokhvalov, et al.
Published: (2019-01-01)

Age and Sex Differences in Hearts of Soluble Epoxide Hydrolase Null Mice
by: K. Lockhart Jamieson, et al.
Published: (2020-02-01)

Lysophosphatidic acids are new substrates for the phosphatase domain of soluble epoxide hydrolase
by: Ami Oguro, et al.
Published: (2012-03-01)

The Soluble Epoxide Hydrolase Inhibitor AR9281 Decreases Blood Pressure, Ameliorates Renal Injury and Improves Vascular Function in Hypertension
by: Sean Shaw, et al.
Published: (2009-12-01)

Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction
by: Yajun Gui, et al.
Published: (2018-05-01)

Soluble Epoxide Hydrolase Hepatic Deficiency Ameliorates Alcohol-Associated Liver Disease
by: Aline Mello, et al.
Published: (2021-01-01)

Inhibitory activity of lignanamides isolated from hemp seed hulls(Cannabis sativa L.) against soluble epoxide hydrolase
by: Jang Hoon Kim, et al.
Published: (2023-09-01)

Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage
by: Chun-Hu Wu, et al.
Published: (2017-11-01)

A thiol redox sensor in soluble epoxide hydrolase enables oxidative activation by intra-protein disulfide bond formation
by: Rebecca L. Charles, et al.
Published: (2021-10-01)

11,12-EET Regulates PPAR-γ Expression to Modulate TGF-β-Mediated Macrophage Polarization
by: Xiaoming Li, et al.
Published: (2023-02-01)